MedTrace Logo

Maekmoondong-tang on Post-operative Cough in Patients With Lung Cancer

NCT03384667 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2018-02-28

No results posted yet for this study

Summary

The aim of the present study is to evaluate the efficacy and safety of Maekmoondong-tang on post-operative cough in patients with lung cancer. A randomized, double-blind, placebo-controlled trial will be conducted.

Conditions

Interventions

DRUG

Maekmoondong-tang

MMDT is a Herbal medicine consist of six herbs.

DRUG

Placebo

The granules do not contain any active ingredients.

Sponsors & Collaborators

  • Seong-Gyu Ko

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-22
Primary Completion
2018-12-31
Completion
2019-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03384667 on ClinicalTrials.gov